Venue
Date
Recording and Reporting
NTP MOP Chapter 5
Rationale
Policies on
Recording & Reporting General Procedures on Recording
a. Use appropriate ink color for paper records.
• Use red ink for positive laboratory results (i.e., Xpert MTB/RIF,
Smear Microscopy, and TBC results), and resistance to drugs
(i.e., LPA and DST results).
• Use black ink for all other records not mentioned above.
b. The physician or immediate supervisor is responsible in
ensuring accuracy and consistency of data recorded.
Policies on
Recording & Reporting General Procedures on Recording
c. Ensure good recording practices. For corrections in paper
records, strike through wrong or outdated information and
correct or update data. Countersign correction with initials of
staff and date. For electronic records, the audit trail reflects
corrections made.
d. Update records daily.
e. Ensure newest form is used.
Policies on
Recording & Reporting General Procedures on Recording
f. Do not leave any blanks. Indicate “N/A” if not applicable to
patient or patient is ineligible, “ND” for not done if patient is
eligible but activity was not done, “none” or “0” if nothing,
and “Unk” if unknown by health staff or patient, accordingly.
g. The ITIS serves as the official TB register and records may be
encoded directly from Treatment card to ITIS.
Policies on
Recording & Reporting Standard Recording
Name SURNAME first in capital letters, followed by Given Names and Name Extensions then
Middle Name (e.g., DELA CRUZ, Juan Jr. Santos)
Sex M or F
DOT Three letter initial of Treatment Supporter or Healthcare Worker
X – Drugs not taken/Absent
I - Incomplete Regimen
H – Drug Holiday
HOLD – On Hold
Re-challenge – Drug re-challenge
Encircle date of regimen change including shift to CP
Double slash for shift to CP
Contact No. Include area code and country code if outside the country (e.g., 632-8230926)
Date MM/DD/YYYY
Policies on
Recording & Reporting Standard Recording: Xpert MTB/RIF
Notation Interpretation
T MTB detected, Rifampicin resistance not detected
RR MTB detected, Rifampicin resistance detected
TI MTB detected, Rifampicin resistance indeterminate
N MTB not detected
I Invalid/ No result/ Error
Policies on
Recording & Reporting Standard Recording: TB LAMP
Reading Notation Interpretation
MTB detected, the sample fluoresce
Positive P
under the UV light.
MTB not detected, the sample did not
Negative N
fluoresce under the UV light.
Sample with incomplete fluorescence as
compared to the positive control; this
Indeterminate I should be repeated using the same
sample. If the second test result is still the
same, release the result as Indeterminate.
Policies on
Recording & Reporting Standard Recording: LPA
Field Result Notation
M. tb Detected MTb
M. Tuberculosis 0
M. tb Not Detected
Complex Result
Invalid I
Resistance Detected R
First Line LPA and Resistance Not Detected S
Second Line LPA Resistance Indeterminate I
Not Applicable N/A
Policies on
Recording & Reporting General Procedures on Reporting
Submission Validation
Reports Cohort Reported
Deadline Deadline
1. Report 1a. Quarterly Report on Xpert MTB/RIF, Smear Microscopy,
and TB LAMP
2. Report 1b. Quarterly Report on Line Probe Assay Q1 Current Year April 30 April 30
3. Report 1c. Quarterly Report on TB Culture
4. Report 1d. Quarterly Report on Drug Susceptibility Testing
5. Report 2. Quarterly Report on External Quality Assessment for TB
April 30 April 30
Smear Microscopy
Q1 Current Year
6. Report 3. Quarterly Report on TB and TB Preventive Notification
(Q4 Previous Year for Enrolment April 30 April 30
and Treatment
Status, HIV, DM)
7. Report 4a. Monthly Report on FLD, Smear Microscopy, and Xpert
Inventory and Requirement March Current Year April 10 April 10
8. Report 4b. Monthly Report on SLD Inventory and Requirement
Q1 Previous Year for DSTB, TPT,
DRTB Interim
9. Report 5. Quarterly Report on TB and TB Preventive Treatment
Q1 Two Years Ago for DRTB April 30 April 30
Outcomes
Q1 Three Years Ago for DRTB
Post Tx
Program Changes Facility Code
Digit 1 2 3 4 5 6 7 8 9 10 11 12
Sample P H N T - 0 6 0 6 - 0 0 1 - A
Level 1st 2nd 3rd 4th 5th
1st level – PH represents the Philippines standard country code
2nd level – NTP represents National TB Control Program
3rd – 0606 represent Antique province in Region VI; official PSGC code
4th – 001 represents this is the first of the nth facility created in the database
5th – represents the facility type
Program Changes Facility Code
Facility Type Patient Type
D – DOTS S – DS-TB
I – iDOTS R – DR-TB
P – PMDT S/TC I – TPT
L – Laboratories
N – Notifying
O – Office
Q – QA Center
W – Warehouse
R – DOTS Referring
Program Changes Patient
Digit 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Sample P H N T - 0 6 0 6 - 0 0 1 - S 1 8 - 0 0 1
Level 1st 2nd 3rd 4th 5th 6th 7th
1st level – PH represents the Philippines standard country code
2nd level – NTP represents National TB Control Program
3rd level – 0606 represent Antique province in Region VI; official PSGC code
4th – 001 represents this is the first of the nth facility created in the database
5th – represents the patient type (DS/DR/TPT)
6th – represents the year (YY)
7th – 001 represents this is the first of the nth patient created in the database
http://bit.ly/mop6forms
PDF
Password: mop6forms
FORMS
According to Services of Facility
Facility Records
Health Facility with TB Services 1. Form 1. Presumptive TB Masterlist
2. Form 2a. Laboratory Request and Result Form
3. Form 2b. Laboratory Result Form for HIV testing of TB Patients
4. Form 2c. Line Probe Assay Result Form*
5. Form 2d. TB Culture Result Form*
6. Form 2e. Drug Susceptibility Testing Result Form*
7. Form 4b. DS-TB Treatment Card
8. Form 4c. DR-TB Treatment Card
9. Form 4d. TB Preventive Treatment Card
10. Form 5. Patient Booklet
11. Form 6a. DS-TB Register
12. Form 6b. DR-TB Register
13. Form 6c. TPT Register
14. Form 7. Referral Form
Mandatory Notification for Public and Private Providers 1. Form 4a. TB Notification Form
2. Form 2a. Laboratory Request and Result Form
3. Form 7. Referral Form
Laboratory 1. Form 2a. Laboratory Request and Result Form*
2. Form 2c. Line Probe Assay Result Form*
3. Form 2d. TB Culture Result Form*
4. Form 2e. Drug Susceptibility Testing Result Form*
5. Form 3a. Laboratory Register for Xpert MTB/RIF
6. Form 3b. Laboratory Register for Smear Microscopy and TB LAMP
7. Form 3c. Laboratory Register for Line Probe Assay
8. Form 3d. Laboratory Register for TB Culture and DST
Form 1. Presumptive TB
Masterlist
Highlights Form 1. Presumptive TB Masterlist
HIGHLIGHT OF CHANGES
Improved integration of DS-TB and DR-TB
Integration of Presumptive Masterlist and Referral Logbook (work/
diagnostic flow tool)
• From patient demographics, risk factors, and diagnostic tests, to diagnosis,
and tracking of patients
Harmonization of legends from other NTP forms
Space for:
Diagnosis
Action Taken
ACF, ICF, ECF efforts
Form 1. Presumptive Masterlist
NEW FIELD
SURNAME in capital PCF - Passive Case Finding;
letters, Given Names, ACF - Active Case Finding;
Name Extension, and ICF - Intensified Case Finding;
Middle Name ECF- Enhanced Case Finding
Form 1. Presumptive Masterlist
Xpert in first column, NEW FIELD
• Choose one. Required field. NEW FIELD
Smear/ LAMP moved to Tracking of patients is a
second column; Result • Date Registered = Date Notified =
required field
on top of COLLECTION Date Notification Form/ Treatment
date Card Opened
• Notify as soon as diagnosed. Other Diagnostic Tests
TB Case No. of Index
Form 1a. Presumptive Masterlist Insert NEW FORM
Summary of Case
Finding Activities
Number of Target Population
who were screened for
Symptoms or underwent CXR
Among screened, number
with TB symptoms or with
CXR suggestive of TB
Target Group or Area,
Organizer/ Funder
Form 2. Lab
Request & Results
Forms
Highlights Form 2. Lab Request & Result Forms
HIGHLIGHT OF CHANGES
Change of terminologies (DSSM to Smear Microscopy)
Change in sequence of Xpert and Smear
Removal of Registration Group
Inclusion of Paragonimiasis
Inclusion of Time
Allotment of space for Rejection of Specimen and Supervisor
Signature
Form 2a. Laboratory Request and Result Form
[REDUCED FIELD: Removed Reg Group]
Required only if Diagnosis or Baseline
NEW FIELD
NEW FIELD
For paragonimiasis implementing
sites only
NEW FIELD
Form 2a. Laboratory Request and Result Form
NEW FIELD
Allotted space for receiving
notes of Med Tech
• From landscape to portrait
• Included paragonimiasis &
TB LAMP
• Changed sequence of Xpert
and Smear
NEW FIELD
Allotted space for supervisor/s
NEW FIELD
Tracking of time in lab process
Form 2c. Line Probe Assay Result Form
SAME FORM
Update field names/labels
Form 2d. TB Culture Result Form
SAME FORM
Update field names/labels
Form 2e. Drug Susceptibility Testing Result Form
SAME FORM
Update field names/labels
Form 3.
Laboratory Registers
Highlights Form 3. Laboratory Registers
HIGHLIGHT OF CHANGES
Removal of Registration Group
Inclusion of Time
Change in numbering sequence
Inclusion of TB LAMP
Form 3a. Laboratory Register for Xpert MTB/RIF
Form 3b. Laboratory Register for Smear Microscopy and TB LAMP
Form 4. TB &
Treatment
TPT Card
Highlights Form 4. TB and TPT Notification & Treatment Cards
HIGHLIGHT OF CHANGES
Same “look” for MN, DS, DR, and TPT
Insertion of Privacy Notice to Patient
Harmonization of Legends
Recording of Mode of Screening (PCF, ACF, ICF, ECF)
Integration of PPRF
Addition of all laboratory monitoring
Space for Post-treatment Ff-up & Post-treatment Outcome
Updating of new drugs
Form 4a. TB Notification Form MN will include notification of DR-TB
Form 4b. DS-TB Treatment Card
Form 4b. DS-TB Treatment Card
Form 4b. DS-TB Treatment Card
Form 4b. DS-TB Treatment Card
Form 4c. DR-TB Treatment Card
NEW FIELD
Privacy Notice
Date of Notification = Date
Treatment Card Opened
(ideally same as Date of
Diagnosis) NEW FIELD
Mode of Screening
Date of Diagnosis = Date Lab
Result was Received or
Physician Decided Treatment
UPDATE OPTION
Others = Unknown History
Form 4c. DR-TB Treatment Card
NEW FIELD
DM Status
UPDATED OPTIONS
New DR-TB Regimens
Form 4c. DR-TB Treatment Card
NEW FIELDS
• Choose 1 among 3: FB, CB, SA
• DAT can be add-on to any of the 3
• If there are changes, follow rule on correcting records
• Tx Supporter 3-letter initials: Supervised
• STC/ TS/ CB/ SA: Satellite Treatment
Center/ Treatment Site/ Community-Based/
Self-administered DOT NEW FIELD
• X: Drugs not taken/ Absent % Adherence =
• I: Incomplete Regimen Monthly Dose / Expected Number of Days
• Split box for injectable
• H: Drug Holiday NEW FIELD
• HOLD: On hold Height required for Children
• Re-challenge: Drug re-challenge
• Encircle date of regimen change
• Double slash on shift to CP
Form 4c. DR-TB Treatment Card
NEW FIELD NEW FIELD
TB MAC Presentation Tracking of Reporting AEs
Form 4c. DR-TB Treatment Card
NEW FIELD
Other Laboratory and Diagnostic Tests
• Indicate slash to signify schedule
• Once done, indicate actual date done MM/DD
• Record results or findings in PPRF
Form 4c. DR-TB Treatment Card
NEW FIELD
PPRF integrated in
Treatment Card
Form 4c. DR-TB Treatment Card
UPDATED FIELD
From household contacts to close
contacts
NEW FIELD
Post-treatment outcome
Form 4d. TB Preventive Treatment Card
Form 4d. TB Preventive Treatment Card
Form 5.
Patient Booklet
Highlights Form 5. Patient Booklet
HIGHLIGHT OF CHANGES
Integration of Certificate of Completion and Health Education
Materials
Mirroring of Treatment Card
TB Classification
Sputum Monitoring
Administration of Drugs
Form 5. Patient Booklet
Basic Info in the Patient
and Facility
Kasunduan Treatment Completion Certificate
Privacy Rights
Form 5. Patient Booklet
TB Classification and
Treatment Supporter Sputum Monitoring
Regimen
Information
Form 5. Patient Booklet
Mirror of Treatment Card
To add: space for notes & post-tx follow-up
Form 6. TB
Registers
Highlights Form 6. TB Registers
HIGHLIGHT OF CHANGES
Optional to maintain in Paper
Additional columns
• DS and DR
• Contact tracing
• DM testing
• Treatment supporter
• Post-treatment ff-up
• TPT
• Indication for TPT
• Regimen
Form 6a. DS-TB Register
Form 6a. DS-TB Register
Form 6b. DR-TB Register
NEW FIELD
Mode of Screening
NEW FIELD
NEW FIELD
Contact Tracing
DM Status
Form 6b. DR-TB Register
NEW FIELD
Post-Treatment Outcome
Form 6c. TPT Register
Form 7. NTP
Referral Form
Highlights NTP Referral Form
HIGHLIGHT OF CHANGES
Updated Reasons for Referral
• More detailed information for patients for continuation of
treatment
Additional data for International Referrals
• Consent to share information
• Contact information on country of destination
Form 7. Referral Form
UPDATED FIELD
Additional TB Data
Form 7. Referral Form
Form 7. Referral Form
NEW FIELD
Country of Destination
Consent to Share Data
